Royce & Associates LP Sells 27,226 Shares of Houlihan Lokey, Inc. (NYSE:HLI)

Royce & Associates LP lessened its stake in shares of Houlihan Lokey, Inc. (NYSE:HLI) by 18.2% in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 122,456 shares of the financial services provider’s stock after selling 27,226 shares during the period. Royce & Associates LP’s holdings in Houlihan Lokey were worth $19,350,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Opal Wealth Advisors LLC bought a new position in shares of Houlihan Lokey during the 2nd quarter valued at about $26,000. Crewe Advisors LLC boosted its holdings in shares of Houlihan Lokey by 264.5% during the 2nd quarter. Crewe Advisors LLC now owns 226 shares of the financial services provider’s stock valued at $30,000 after purchasing an additional 164 shares during the last quarter. Wolff Wiese Magana LLC bought a new position in shares of Houlihan Lokey during the 3rd quarter valued at about $38,000. Ashton Thomas Private Wealth LLC purchased a new stake in shares of Houlihan Lokey during the 2nd quarter valued at about $38,000. Finally, Benjamin F. Edwards & Company Inc. raised its position in shares of Houlihan Lokey by 69.1% during the 2nd quarter. Benjamin F. Edwards & Company Inc. now owns 678 shares of the financial services provider’s stock valued at $91,000 after buying an additional 277 shares in the last quarter. Institutional investors own 78.07% of the company’s stock.

Houlihan Lokey Price Performance

Houlihan Lokey stock opened at $184.05 on Friday. Houlihan Lokey, Inc. has a 1-year low of $102.29 and a 1-year high of $190.66. The firm has a market capitalization of $12.80 billion, a P/E ratio of 37.64 and a beta of 0.65. The company’s 50-day moving average is $166.88 and its 200 day moving average is $149.50.

Houlihan Lokey (NYSE:HLI) last posted its quarterly earnings data on Wednesday, October 30th. The financial services provider reported $1.46 earnings per share for the quarter, topping analysts’ consensus estimates of $1.31 by $0.15. The company had revenue of $574.96 million for the quarter, compared to analyst estimates of $537.93 million. Houlihan Lokey had a net margin of 15.77% and a return on equity of 19.29%. The firm’s revenue for the quarter was up 23.1% on a year-over-year basis. During the same period in the prior year, the company posted $1.11 EPS. Research analysts anticipate that Houlihan Lokey, Inc. will post 5.79 earnings per share for the current fiscal year.

Houlihan Lokey Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Sunday, December 15th. Shareholders of record on Monday, December 2nd will be paid a $0.57 dividend. The ex-dividend date of this dividend is Monday, December 2nd. This represents a $2.28 dividend on an annualized basis and a yield of 1.24%. Houlihan Lokey’s dividend payout ratio is currently 46.63%.

Insiders Place Their Bets

In other Houlihan Lokey news, Director Gillian Beth Zucker sold 200 shares of the company’s stock in a transaction dated Friday, September 13th. The shares were sold at an average price of $152.28, for a total value of $30,456.00. Following the transaction, the director now directly owns 6,801 shares in the company, valued at $1,035,656.28. This represents a 2.86 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, General Counsel Christopher M. Crain sold 1,000 shares of the company’s stock in a transaction dated Tuesday, September 3rd. The stock was sold at an average price of $155.29, for a total transaction of $155,290.00. The disclosure for this sale can be found here. Insiders have sold 1,600 shares of company stock worth $249,860 in the last three months. Corporate insiders own 23.68% of the company’s stock.

Analyst Upgrades and Downgrades

Several brokerages have recently issued reports on HLI. StockNews.com upgraded shares of Houlihan Lokey from a “hold” rating to a “buy” rating in a research report on Tuesday. UBS Group upped their target price on shares of Houlihan Lokey from $170.00 to $190.00 and gave the company a “buy” rating in a research report on Tuesday, October 8th. Morgan Stanley upped their target price on shares of Houlihan Lokey from $146.00 to $163.00 and gave the company an “equal weight” rating in a research report on Monday, September 23rd. JPMorgan Chase & Co. decreased their target price on shares of Houlihan Lokey from $132.00 to $129.00 and set a “neutral” rating on the stock in a research report on Wednesday, July 31st. Finally, Keefe, Bruyette & Woods restated a “market perform” rating and set a $154.00 target price (up from $139.00) on shares of Houlihan Lokey in a research report on Wednesday, July 31st. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and two have given a buy rating to the company. According to MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $157.00.

Houlihan Lokey Company Profile

Houlihan Lokey, Inc, an investment banking company, provides merger and acquisition (M&A), capital market, financial restructuring, and financial and valuation advisory services worldwide. It operates in three segments: Corporate Finance, Financial Restructuring, and Financial and Valuation Advisory.